A detailed history of Black Rock Inc. transactions in Myriad Genetics Inc stock. As of the latest transaction made, Black Rock Inc. holds 15,150,806 shares of MYGN stock, worth $232 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,150,806
Previous 14,879,319 1.82%
Holding current value
$232 Million
Previous $317 Million 16.82%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$17.98 - $25.47 $4.88 Million - $6.91 Million
271,487 Added 1.82%
15,150,806 $371 Million
Q1 2024

May 10, 2024

BUY
$17.59 - $23.59 $3.89 Million - $5.21 Million
220,970 Added 1.51%
14,879,319 $317 Million
Q4 2023

Feb 13, 2024

BUY
$13.91 - $21.32 $14.3 Million - $22 Million
1,031,424 Added 7.57%
14,658,349 $281 Million
Q3 2023

Nov 13, 2023

SELL
$15.99 - $23.22 $7.64 Million - $11.1 Million
-477,679 Reduced 3.39%
13,626,925 $219 Million
Q2 2023

Aug 11, 2023

SELL
$17.56 - $23.76 $405,706 - $548,951
-23,104 Reduced 0.16%
14,104,604 $327 Million
Q1 2023

May 12, 2023

SELL
$15.26 - $23.75 $3.49 Million - $5.42 Million
-228,391 Reduced 1.59%
14,127,708 $328 Million
Q4 2022

Feb 13, 2023

SELL
$14.51 - $20.99 $3.3 Million - $4.77 Million
-227,096 Reduced 1.56%
14,356,099 $208 Million
Q3 2022

Nov 14, 2022

SELL
$18.21 - $27.88 $3.19 Million - $4.88 Million
-175,205 Reduced 1.19%
14,583,195 $278 Million
Q2 2022

Aug 12, 2022

SELL
$16.45 - $25.88 $648,607 - $1.02 Million
-39,429 Reduced 0.27%
14,758,400 $268 Million
Q1 2022

May 12, 2022

BUY
$22.67 - $28.01 $2.56 Million - $3.17 Million
113,042 Added 0.77%
14,797,829 $373 Million
Q4 2021

Feb 10, 2022

BUY
$24.13 - $32.63 $27.1 Million - $36.7 Million
1,123,482 Added 8.28%
14,684,787 $405 Million
Q3 2021

Nov 09, 2021

SELL
$29.97 - $36.66 $1.27 Million - $1.55 Million
-42,365 Reduced 0.31%
13,561,305 $438 Million
Q2 2021

Aug 11, 2021

BUY
$25.39 - $32.61 $345 Million - $444 Million
13,603,670 New
13,603,670 $416 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.23B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.